Primary Outcome Measures:
- Subject survival at 30-days and one-year post transplant [ Time Frame: 30-days and one-year post transplant ]
Device: CardioWest temporary Total Artificial Heart (TAH-t)
The SynCardia CardioWest temporary Total Artificial Heart (TAH-t) system is a pulsatile biventricular device that replaces a patient's native ventricles and valves and pumps blood to both the pulmonary and systemic circulation. The system consists of the implantable CardioWest TAH-t and an external console connected by drivelines.